Cargando…

Risk Factors Associated With Hospitalization and Death in COVID-19 Breakthrough Infections

BACKGROUND: Characterizations of coronavirus disease 2019 (COVID-19) vaccine breakthrough infections are limited. We aim to characterize breakthrough infections and identify risk factors associated with outcomes. METHODS: This was a retrospective case series of consecutive fully vaccinated patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suleyman, Geehan, Fadel, Raef, Brar, Indira, Kassab, Rita, Khansa, Rafa, Sturla, Nicholas, Alsaadi, Ayman, Latack, Katie, Miller, Joseph, Tibbetts, Robert, Samuel, Linoj, Alangaden, George, Ramesh, Mayur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903475/ https://www.ncbi.nlm.nih.gov/pubmed/35437511 http://dx.doi.org/10.1093/ofid/ofac116

Ejemplares similares

Progression to Critical Illness and Death in Patients With Breakthrough Hospitalizations
por: Suleyman, Geehan, et al.
Publicado: (2022)

569. Characterization of COVID-19 Vaccine Breakthrough Infections in Metropolitan Detroit
por: sturla, Nicholas, et al.
Publicado: (2021)

753. Impact of COVID-19 on Healthcare Facility-Onset Clostridiodes difficile Infection
por: Suleyman, Geehan, et al.
Publicado: (2021)

779. COVID-19 Pandemic and Catheter-associated Urinary Tract Infection Trends
por: Suleyman, Geehan, et al.
Publicado: (2021)

770. Impact of COVID-19 Pandemic on Central Line-associated Bloodstream Infections in Metropolitan Detroit
por: Suleyman, Geehan, et al.
Publicado: (2021)

Outcomes associated with SARS-CoV-2 reinfection in individuals with natural and hybrid immunity
por: Suleyman, Geehan, et al.
Publicado: (2023)

Low- Versus High-Dose Methylprednisolone in Adult Patients With Coronavirus Disease 2019: Less Is More
por: Joshi, Seema, et al.
Publicado: (2021)

444. Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers in Southeast Michigan
por: Vahia, Amit T, et al.
Publicado: (2020)

Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit
por: Suleyman, Geehan, et al.
Publicado: (2020)

Clinical Impact of Nucleic Acid Amplification Testing in the Diagnosis of Mycobacterium Tuberculosis: A 10-Year Longitudinal Study
por: Bourgi, Kassem, et al.
Publicado: (2017)

500. A Real-World Cohort Study of Bamlanivimab Versus Bamlanivimab-Etesevimab for Non-severe COVID-19
por: Monday, Lea, et al.
Publicado: (2021)

Cardiac sequelae of novel coronavirus disease 2019 (COVID-19): a clinical case series
por: Demertzis, Zachary D, et al.
Publicado: (2020)

407. Utilization of Blood Cultures, Risk factors and Outcomes of Bloodstream Infections in Patients Hospitalized with COVID-19
por: Gudipati, Smitha, et al.
Publicado: (2020)

Role of diagnostic stewardship in reducing healthcare-facility–onset Clostridioides difficile infections
por: Shallal, Anita B., et al.
Publicado: (2023)

344. VersaTrek versus Virtuo Blood Culture System’s Effect on Diagnostic Test Utilization and Patient Outcomes, a Quasi-Experimental Study
por: Dillon, William P, et al.
Publicado: (2022)

2031. Role of Urine Culture Hard Stop in Reducing Catheter-associated Urinary Tract Infections
por: Cherian, John, et al.
Publicado: (2022)

Microbiology Comment Nudge Improves Pneumonia Prescribing
por: Musgrove, Mary A, et al.
Publicado: (2018)

357. Complications and Outcomes of Obese Patients Hospitalized with COVID-19
por: Shallal, Anita, et al.
Publicado: (2020)

2661. Characterization of Mpox in Southeast Michigan
por: Alvi, Rija B R, et al.
Publicado: (2023)

Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19
por: Fadel, Raef, et al.
Publicado: (2020)

328. Universal PCR Testing- Is It Worth It?
por: Birk, Navina K, et al.
Publicado: (2022)

197. Evaluation of Risk Factors and Outcomes Associated with Daptomycin-nonsusceptible Staphylococcus aureus Bacteremia
por: Hanna, Zachary W, et al.
Publicado: (2023)

Oliguria on the Day of Intubation Is Associated With Mortality in Patients With Acute Respiratory Distress Syndrome
por: Fadel, Raef A., et al.
Publicado: (2022)

607. Candidemia: Role of T2Candida® compared to Bact/Alert Virtuo blood culture system in a real-world setting
por: Birk, Navina K, et al.
Publicado: (2023)

Vaccine breakthrough infections in veterans hospitalized with coronavirus infectious disease-2019: A case series
por: Kim, Paul S., et al.
Publicado: (2022)

A SARS-CoV-2 outbreak associated with vaccine breakthrough in an acute care hospital
por: Park, Se Yoon, et al.
Publicado: (2022)

551. Convalescent plasma early in disease course improves survival in COVID-19
por: Nauriyal, Varidhi, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus 2 Delta Vaccine Breakthrough Transmissibility in Alachua County, Florida
por: Rife Magalis, Brittany, et al.
Publicado: (2022)

497. Moderate Versus High Dose Corticosteroids in Adult Patients with Severe COVID-19: Less Is More
por: Joshi, Seema, et al.
Publicado: (2021)

Impact of Female External Urinary Catheter on Indwelling Catheter Use and Catheter-Associated Urinary Tract Infection Rates
por: Monday, Lea, et al.
Publicado: (2021)

Mechanical Ventilation and Coronavirus Disease 2019: A Case-Control Analysis of Clinical Characteristics, Lung Mechanics, and Mortality
por: Abu Sayf, Alaa, et al.
Publicado: (2021)

Comparison of Roche and Abbott Cytomegalovirus Quantitative PCR Assays in Allogeneic Hematopoetic Cell Transplant Recipients
por: Mckinnon, John, et al.
Publicado: (2017)

Evolution of Humoral and Cellular Immunity Post–Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-Cilgavimab
por: Hall, Victoria G, et al.
Publicado: (2023)

Post-Vaccination Coronavirus Disease 2019: A Case-Control Study and Genomic Analysis of 119 Breakthrough Infections in Partially Vaccinated Individuals( )
por: Baltas, Ioannis, et al.
Publicado: (2021)

Longitudinal Analysis of SARS-CoV-2 Vaccine Breakthrough Infections Reveals Limited Infectious Virus Shedding and Restricted Tissue Distribution
por: Ke, Ruian, et al.
Publicado: (2022)

Differential Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Response in Inactivated Virus–Vaccinated, Convalescent, and Breakthrough-Infected Subjects
por: Duarte, Luisa F, et al.
Publicado: (2023)

Antibody Level Predicts the Clinical Course of Breakthrough Infection of COVID-19 Caused by Delta and Omicron Variants: A Prospective Cross-Sectional Study
por: Kim, Min Hyung, et al.
Publicado: (2022)

A National Implementation Project to Prevent Healthcare-Associated Infections in Intensive Care Units: A Collaborative Initiative Using the Breakthrough Series Model
por: Tuma, Paula, et al.
Publicado: (2023)

High-Dose Influenza Vaccine Is Associated With Reduced Mortality Among Older Adults With Breakthrough Influenza Even When There Is Poor Vaccine-Strain Match
por: Chaves, Sandra S, et al.
Publicado: (2023)

547. Risk Factors Associated with 30-Day Mortality in a Large Cohort of Patients who Received Remdesivir and Corticosteroids for Severe COVID-19
por: Gupta, Kartik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_io1mif9fkojp47ilki5962j116